ArticleFrontiers in medicine2023

Case report: Area of focus of management of severe pityriasis rubra pilaris by dose optimization of adalimumab biosimilar in combination with acitretin and montelukast.

Kristine Heidemeyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.